RETRACTED: Placental serotonin systems in pregnancy metabolic complications associated with maternal obesity and gestational diabetes mellitus
- PMID: 30738809
- DOI: 10.1016/j.bbadis.2019.01.017
RETRACTED: Placental serotonin systems in pregnancy metabolic complications associated with maternal obesity and gestational diabetes mellitus
Retraction in
-
Retraction notice to "Placental serotonin systems in pregnancy metabolic complications associated with maternal obesity and gestational diabetes mellitus." [Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 1866 (2020) 65391].Biochim Biophys Acta Mol Basis Dis. 2021 Mar 1;1867(3):166035. doi: 10.1016/j.bbadis.2020.166035. Epub 2020 Dec 28. Biochim Biophys Acta Mol Basis Dis. 2021. PMID: 33384199 No abstract available.
Abstract
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). The publication was retracted by request of the authors following an investigation by Monash University performed following its Procedures for Investigating Code Breaches and in accordance with the Australian Code for the Responsible Conduct of Research. The University concluded on the balance of probability that a significant part of the text in the paper was included without knowledge, without consent and without correct attribution of the original author who, at the time, was a student at the University. The results discussed in the review article are still scientifically valid. ☆ This article is part of a Special Issue entitled: Membrane Transporters and Receptors in Pregnancy Metabolic Complications edited by Luis Sobrevia.
Keywords: Gestational diabetes mellitus; Inflammation; Obesity; Placenta; Pregnancy; Serotonin metabolic pathway.
Copyright © 2019. Published by Elsevier B.V.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
